Quantcast

Joco Today

Wednesday, September 10, 2025

Senator Marshall questions HHS nominee on innovation and mental health

Webp 7kb7du6y2dm5trkai76qgrrd89h5

Senator Roger Marshall, US Senator for Kansas | Official U.S. House headshot

Senator Roger Marshall, US Senator for Kansas | Official U.S. House headshot

U.S. Senator Roger Marshall, a Republican from Kansas, engaged in a detailed discussion with Dr. James O’Neill, the nominee for Deputy Secretary of the Department of Health and Human Services (HHS), during a recent Senate Committee on Health, Education, Labor and Pensions (HELP) hearing.

Senator Marshall questioned Dr. O’Neill about his plans to innovate at HHS. During the exchange, Senator Marshall asked Dr. O'Neill about his vision for reforming the food system to prioritize health. Dr. O’Neill responded by highlighting the increased attention given to metabolism and chronic diseases over recent years. He noted that "infectious disease is still a very serious challenge," but metabolic disorders are gaining more focus from various stakeholders.

Dr. O'Neill expressed concerns about current nutrition practices, stating that many families struggle to maintain healthy habits due to economic and informational barriers: “Junk food is much cheaper than healthy food,” he said, adding that official dietary guidelines often lag behind current science.

The conversation also touched on mental health issues linked to technology usage among children and young adults. Senator Marshall referenced "The Anxious Generation" book while questioning Dr. O'Neill about social media's impact on mental health. Dr. O’Neill acknowledged this concern, pointing out that app developers aim to maximize user engagement which may not be beneficial for young users: “There’s more and more awareness that social media can be an addiction.”

Finally, they discussed the importance of unbiased testing in scientific research. Senator Marshall emphasized replicating studies as crucial for scientific accuracy and mentioned past misdirections in Alzheimer’s research due to non-replicated studies. Dr. O’Neill agreed on the need for replication: “NIH should devote” resources towards ensuring studies are repeatable without bias.

MORE NEWS